Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.
AUTOR(ES)
Weksler, B B
RESUMO
Cultured endothelial cells derived from human umbilical veins or bovine aorta produce a potent inhibitor of platelet aggregation. The inhibitor is synthesized from sodium arachidonate or or prostaglandin endoperoxides by a microsomal enzyme system. Tranylcypromine, a specific antagonist of prostacyclin synthetase, suppresses production of the inhibitor by endothelial cells. The inhibitor, which is ether extractable, has been identified using a two-step thin-layer radiochromatographic procedure and a synthetic prostaglandin I2 standard.With this procedure, we have shown that human and bovine endothelial cells convert sodium [3H]arachidonate to radiolabeled prostaglandin I2 and 6-keto-prostaglandin F1alpha, as wellas prostaglandin E2. Thus, endothelial cells may be non-thrombogenic in vivo because they synthesize and release prostaglandin I2, a potent inhibitor of platelet aggregation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=431786Documentos Relacionados
- Nitroglycerin Stimulates Synthesis of Prostacyclin by Cultured Human Endothelial Cells
- Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels.
- Leukotriene C promotes prostacyclin synthesis by human endothelial cells.
- Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial Cells
- Effect of fatty acid modification on prostacyclin production by cultured human endothelial cells.
